RecruitingNCT04845893

Observational Study on Skeletal Ewing's Sarcoma

Observational Study on Treatment of Skeletal Ewing Sarcoma at Diagnosis

Sponsor

Italian Sarcoma Group

Enrollment

100 participants

Start Date

Jun 1, 2021

Study Type

OBSERVATIONAL

Conditions

Ewing Sarcoma of Bone

Summary

Observational prospective trial aimed to collect the collect demographic, clinical, surgical, pathological and molecular characteristics and treatment from patients affected by skeletal Ewing Sarcoma

Eligibility

Min Age: 0 YearsMax Age: 49 Years

Plain Language Summary

Simplified for easier understanding

This is an observational study collecting data from patients diagnosed with Ewing's sarcoma — a rare bone cancer — to better understand how the disease behaves, what treatments work, and how outcomes can be improved over time. No experimental treatment is involved. **You may be eligible if:** - You have been diagnosed with Ewing's sarcoma, Ewing-like sarcoma, or a related tumor (such as CIC-rearranged or BCOR-rearranged sarcoma) - You are under 50 years old at the time of diagnosis - You (or your parent/guardian, if a minor) have given written consent to participate **You may NOT be eligible if:** - You have other medical conditions that would make it difficult to complete your treatment plan or be accurately evaluated for outcomes Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTreatment of Ewings Sarcoma of bone according clinical practice (includes drugs, surgery, radiotherapy or any other received treatments)

This observational study collects all the treatments received by the patients according clinical practices or experimental trials and therefore includes drug/biological/surgical/ radiotherapy and any other applicable treatments

Locations(19)

Istituto Clinico Humanitas

Rozzano, MI, Italy

Centro di Riferimento Oncologico - Unit of Medical Oncology

Aviano, Pordenone, Italy

I.R.C.C. - Unit of Medical Oncology

Candiolo, Torino, Italy

Azienda ospedaliero universitaria consorziale policlinico - bari

Bari, Italy

A.O. Universitaria Policlinico S. Orsola Malpighi di Bologna

Bologna, Italy

Istituto ortopedico Rizzoli

Bologna, Italy

A.O. Universitaria Meyer

Florence, Italy

Istituto Giannina Gaslini

Genova, Italy

FONDAZIONE IRCCS Istituto Nazionale dei Tumori

Milan, Italy

FONDAZIONE IRCCS Istituto Nazionale dei Tumori

Milan, Italy

Azienda Ospedaliera Santobono Pausilipon

Naples, Italy

Azienda Ospedaliera di Padova

Padova, Italy

ARNAS P. O. "Civico e Benfratelli"

Palermo, Italy

Azienda Ospedaliera Universitaria di Parma

Parma, Italy

Azienda Ospedaliero-Universitaria Pisana

Pisa, Italy

Ospedale Pediatrico Bambin Gesu'

Roma, Italy

Istituto Regina Elena - IFO

Rome, Italy

Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology

Torino, Italy

IRCCS materno infantile Burlo Garofolo

Trieste, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04845893

Related Trials

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

NCT050332883 locations

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

NCT0606807515 locations